Ramesh Acharya
No más puestos en curso
Perfil
Ramesh Acharya has been Chief Scientific Officer of InSys Therapeutics, Inc. since August 2007.
He is a co-Founder of Oramed.
Prior to joining InSys Therapeutics, he was President of Acharya Consulting Co. from 2002 to August 2007.
Dr. Acharya was an Executive Vice President of Akorn and Vice President of Research for TheraTech.
He received a BSc degree from the University of Bombay, an MS degree in Pharmacy from the University of the Pacific, and a PhD in Pharmacy from the University of Illinois.
Antiguos cargos conocidos de Ramesh Acharya.
| Empresas | Cargo | Fin |
|---|---|---|
| AKORN, INC. | Corporate Officer/Principal | - |
TheraTech, Inc.
 TheraTech, Inc. Medical DistributorsDistribution Services TheraTech, Inc. manufactures and distributes medical devices. The company was founded by Chick Sanford & Dinesh C. Patel in January, 1985 and is located in Hopkins, MN | Director Técnico/Científico/I+D | - |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Director Técnico/Científico/I+D | - |
Formación de Ramesh Acharya.
| University of Mumbai | Undergraduate Degree |
| University of the Pacific | Graduate Degree |
| University of Illinois | Doctorate Degree |
| Northwestern University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
InSys Therapeutics, Inc. /Old/
InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology InSys Therapeutics, Inc. is a pharmaceutical company that develops and seeks to commercialize innovative pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's product pipeline targeting cancer-supportive care and cancer therapy that it believe can be developed cost efficiently and, if approved, commercialized through a targeted commercial organization. Its supportive care product candidates include Fentanyl SL Spray, a proprietary, fast-acting sublingual fentanyl spray for the treatment of breakthrough cancer pain, and its family of dronabinol product candidates for the treatment of chemotherapy-induced nausea and vomiting and appetite stimulation in AIDS patients. The company was founded by Dr. S. George Kottayil and John N. Kapoor on October 18, 2002 and is headquartered in Phoenix, AZ. | Health Technology |
Akorn, Inc.
 Akorn, Inc. Pharmaceuticals: MajorHealth Technology Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It manufactures and markets branded and generic products including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The company was founded in 1971 and is headquartered in Lake Forest, IL. | Health Technology |
TheraTech, Inc.
TheraTech, Inc. Medical DistributorsDistribution Services TheraTech, Inc. manufactures and distributes medical devices. The company was founded by Chick Sanford & Dinesh C. Patel in January, 1985 and is located in Hopkins, MN | Distribution Services |
- Bolsa de valores
- Insiders
- Ramesh Acharya
